🔴 British Dragon

Oxanabol (Anavar)

✔️ Substance: Oxandrolone
✔️ Price For: 100 tabs (10 mg/tab)
✔️ Brand: British Dragon

Out of stock

British Dragon Pharma Oxanabol 10

IDENTITYCompoundOxandrolone
DerivativeDHT Derivative
Strength10 mg/tablet
FormOral Tablet
ClassAnabolic Steroid

PHARMACOLOGYAdministrationOral
Half-LifeApprox. 10–13 Hours
AromatizationMinimal
17α AlkylatedYes
AndrogenicModerate

SAFETYHPTA EffectSuppressive
Liver RiskSignificant
Lipid RiskSignificant
AromatizationMinimal
MonitoringEssential

STORAGE/PACKAGEBrandBritish Dragon Pharma
Package100 Tablets
Strength10 mg/tablet
StorageCool Dry Place
ProtectionHeat & Moisture

DOSINGCommon Range20–50 mg/day
Weekly Total140–350 mg/week
FrequencyDaily Administration
Typical Period6–8 Weeks
TimingSplit Daily Doses

USAGE PROFILERouteOral Administration
ScheduleEvery Day
TimingConsistent Daily Timing
PeriodSeveral Weeks
MonitoringLiver & Lipids

RECOVERYSuppressionPossible
RecoveryIndividualized
PCT StatusNo Universal Protocol
TestingHormonal Panel
Follow-upClinician Guided

STACKING/COMPATIBILITYTestosteroneCommonly Combined
Lean MassTestosterone Based
CuttingAndrogen Combinations
Oral SteroidsHigher Liver Burden
MonitoringLipids & Liver

MECHANISM OF ACTIONTargetAndrogen Receptor
StructureDHT Derived
ProteinSynthesis Support
NitrogenPositive Balance
AromataseMinimal Substrate

PHARMACOKINETICSAbsorptionOral
Half-Life10–13 Hours
MetabolismHepatic
ExposureDaily Administration
ClearanceMetabolic

CONTRAINDICATIONSLiver DiseaseContraindicated
PregnancyContraindicated
ProstateAssess Clinically
LipidsMonitor Closely
CardiovascularRisk Assessment

COMPARISONS/ALTERNATIVESOxandroloneDHT Derivative
MethenoloneDHT Related
DrostanoloneDHT Derived
Stanozolol17α Alkylated
TestosteroneAromatizable Androgen

CHEMICAL PROFILEFormulaC19H30O3
Weight306.44 g/mol
CAS53-39-4
ClassOxandrolone
ATCA14AA08

WHO IT'S FORClinical UseSpecific Indications
AthletesNon-Medical Use
WomenVirilization Risk
MonitoringMedical Supervision
PurposeIndication Dependent

BODYBUILDING USAGE

Commonly discussed during cutting
Also used for lean-mass phases
Oral administration simplifies scheduling
Does not aromatize significantly
Lipid suppression remains important
Liver monitoring remains necessary
Endogenous testosterone may decrease

WHAT IS BRITISH DRAGON?

British Dragon Pharma is the brand identified for this Oxanabol product. Brand identity alone does not establish pharmaceutical authenticity, sterility, potency or manufacturing quality. Product-specific documentation and independent verification are therefore important when evaluating any non-standard pharmaceutical product.

WHY CHOOSE BRITISH DRAGON?

Specified active compound
Defined tablet strength
Clearly identified formulation
Consistent product labeling
Batch verification is important
Independent testing remains valuable

OVERVIEW

British Dragon Pharma Oxanabol is identified as an oral formulation containing oxandrolone, a synthetic anabolic-androgenic steroid derived from dihydrotestosterone. Oxandrolone is a 17α-alkylated steroid that has been used medically for promoting weight gain following catabolic states and for other specific indications. Its pharmacological activity is mediated primarily through androgen-receptor signaling.

BENEFITS

Supports anabolic signaling
Supports protein synthesis
Minimal estrogen conversion
Oral administration
Lean-mass oriented profile
Potential strength support
DHT-derived structure

POTENTIAL SIDE EFFECTS

HDL cholesterol reduction
LDL cholesterol elevation
Liver enzyme elevation
Endogenous testosterone suppression
Acne and oily skin
Hair loss susceptibility
Virilization in women
Blood pressure changes
Reduced fertility

PERFORMANCE PROFILE

Lean Mass

78%

Strength

76%

Muscle Retention

84%

Water Retention

10%

Liver Burden

65%

OXANDROLONE FOR SALE

Oxanabol 10 is identified as a British Dragon Pharma product containing 10 mg oxandrolone per tablet. Product identity, concentration and authenticity should be independently verified where possible. Information about availability or commercial status should not be interpreted as evidence of regulatory approval or product quality.

CONCLUSION

Oxanabol contains oxandrolone, a synthetic DHT-derived anabolic-androgenic steroid with oral activity. Its 17α-alkylated structure permits oral administration but also contributes to clinically relevant hepatic and lipid considerations. Oxandrolone does not significantly aromatize to estrogen, although this does not make it risk-free.

Bodybuilding literature commonly discusses oxandrolone in lean-mass and cutting contexts, but these applications are distinct from its approved medical uses. There is no universally validated athletic dosing or PCT protocol that can be considered an established medical standard.

For educational purposes, readers should distinguish pharmacological characteristics from performance claims and consider endocrine, hepatic, cardiovascular and lipid monitoring when evaluating the compound's risk profile.

Disclaimer

This content is provided exclusively for educational and informational purposes. It does not constitute medical advice, treatment recommendations or endorsement of non-medical anabolic steroid use. Athletic dosing and cycle protocols are not established clinical standards. Oxandrolone can produce significant endocrine, hepatic and cardiovascular effects. Readers should consult qualified healthcare professionals regarding medical questions, laboratory monitoring and applicable laws in their jurisdiction.